Skip to content

tDCS and Motor Training and Motor Deficit After Stroke

Effects of Anodal tDCS and Motor Training on Chronic Motor Deficit After Stroke

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02542982
Enrollment
26
Registered
2015-09-07
Start date
2013-04-30
Completion date
2015-03-31
Last updated
2015-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

tDCS, motor recovery

Brief summary

This study investigated the combined effects of anodal tDCS and intensive motor training (MT) vs. sham stimulation with MT (control intervention) on grip strength, motor performance and functional use of the affected arm in population of chronic stroke patients.

Detailed description

A growing body of evidence are available regarding the effectiveness of anodal transcranial direct current stimulation (tDCS) in patients with chronic hand motor impairment as a stroke consequence. This study investigated the combined effects of anodal tDCS and intensive motor training (MT) vs. sham stimulation with MT (control intervention) on objective evaluation of fine and gross motor hand function using simulated activities of daily living (Jebsen-Taylor hand function test), grip strength, motor performance and functional use of the affected arm in this population of patients. Patients with chronic hand motor deficits after stroke (\> 12 months) are randomly assigned to active stimulation or a control intervention arm in a double-blinded, sham-controlled, parallel design. Each group received intensive MT for 45 min/day, 5 days/week, for 2 weeks, which was preceded by 20 minutes of 2 milliampere of anodal tDCS over the ipsilesional M1 vs. sham tDCS. Outcome measures are tested at baseline (T0), and after the intervention Day 1 (T1), after stimulation protocol completion Day 10 (T2) and 30 days later (T3).

Interventions

DEVICEtDCS (Endomed 482; Enraf-Nonius B.V.)

non-invasive brain stimulation with pair of electrodes with saline-soaked pads through which the direct current of intensity of 2 mA is delivered

Sponsors

Clinical Centre of Serbia
CollaboratorOTHER
Military Medical Academy, Belgrade, Serbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* diagnosis of stroke made by clinical features and documented by neuroimaging studies (CT or MRI scans * stroke duration \> 12 months * severe hand deficit at stroke onset (Medical Research Council grade \<2) and * subsequently recovered to the level moderate hand deficit with presence of hand movements evaluated by the Fugl-Meyer upper-extremity Assessment (FMA) of Motor Recovery after Stroke between 28-50 points (max. 66 pts), * spasticity between 0-2 assessed on the Modified Ashworth Scale

Exclusion criteria

* any clinically significant or unstable medical disorder, * diagnosis od major depression, * diagnosis odf substance or alcohol abuse or any neurological disorder other than stroke, including neglect, aphasia, hemianopsia and serious cognitive impairment (Mini-Mental State Examination \< 24). * any contraindications to tDCS, including histories of seizure, cerebral aneurysm, and prior surgery involving metallic implants

Design outcomes

Primary

MeasureTime frameDescription
Jebsen Taylor Test of Hand Functionone day, two weeks and one monthchanges of baseline summed times to complete six individual tasks (from JTT-2 to JTT7) and is performed with each hand separately

Secondary

MeasureTime frameDescription
hand grip forcetwo weeks and one monthchanges of baseline maximum grip force of the hand measured by whole-hand dynamometer
upper limb Fugl-Meyer assessment of Motor Recovery after Strokeone day, two weeks and one monthchanges of initial score from domain of motor functions for upper limb

Countries

Serbia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026